Triglyceride Thresholds for Reducing or Holding Parenteral Lipids
Consider reducing parenteral lipid dosage when serum triglycerides exceed 265 mg/dL (3 mmol/L) in infants or 400 mg/dL (4.5 mmol/L) in older children and adults during infusion. 1
Age-Based Thresholds
The ESPGHAN/ESPEN/ESPR/CSPEN 2018 guidelines provide clear, age-stratified cutoffs:
Infants (including preterm and term)
- Reduce lipid dose when triglycerides >265 mg/dL (3 mmol/L) during infusion 1
- This threshold is based on evidence showing no increased neonatal morbidities (necrotizing enterocolitis, bronchopulmonary dysplasia, retinopathy of prematurity, intraventricular hemorrhage) at this level in very low birth weight infants 1
- Preterm infants are at higher risk due to limited muscle/fat mass and decreased hydrolytic capacity 1
Older Children and Adults
- Reduce lipid dose when triglycerides >400 mg/dL (4.5 mmol/L) during infusion 1
- This threshold reflects the saturation point of lipoprotein lipase at approximately 4.5 mmol/L 1
- Acceptable range during infusion: 300-400 mg/dL (3.4-4.5 mmol/L) 1
Critical Management Points
Reduce, Don't Stop
The guidelines explicitly state: lower the dosage, not stop it entirely when triglycerides exceed these thresholds 1. Complete cessation risks essential fatty acid deficiency.
Timing of Measurement
- Check triglycerides during infusion (not fasting) 1
- Hypertriglyceridemia most likely occurs 4 hours after infusion initiation 1
- For home PN patients on intermittent infusions, assess 12 hours after discontinuation 1
Address Root Causes First
Before reducing lipids, evaluate and correct:
- Excessive glucose administration - Lipogenesis from high glucose can cause hypertriglyceridemia; reduce glucose first 1
- Sepsis - Increases hypertriglyceridemia risk; requires more frequent monitoring 1
- Other high-risk conditions: extremely low birth weight, malnutrition, catabolism 1
Monitoring Algorithm
Initial monitoring:
- Check triglycerides 1-2 days after starting or adjusting lipid infusion 1
Ongoing monitoring:
- Stable patients: Weekly to monthly 1
- High-risk patients (sepsis, high glucose/lipid doses, ELBW, malnourished): More frequent monitoring required 1
Additional Context from Adult Guidelines
The 2009 ESPEN intensive care guidelines recommend a more conservative approach for adults: reduce dosage at >400 mg/dL (>4.6 mmol/L) and interrupt lipid infusion at >1000 mg/dL (>11.4 mmol/L) 2. However, the pediatric guidelines are more recent (2018) and provide more nuanced, age-specific recommendations that should guide practice.
Common Pitfalls to Avoid
- Don't completely stop lipids - This risks essential fatty acid deficiency; always maintain at least minimal EFA requirements 1
- Don't assume glucose is innocent - Hypertriglyceridemia from excess glucose is common; address this before blaming lipids 1
- Don't use fasting levels - Measure during infusion for accurate assessment of lipid tolerance 1
- Don't ignore clinical context - Sepsis, malnutrition, and prematurity all increase risk and warrant closer monitoring 1